See more : Bubs Australia Limited (BUBSF) Income Statement Analysis – Financial Results
Complete financial analysis of Perfect Medical Industry Co., Ltd. (6543.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Perfect Medical Industry Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Tencent Holdings Limited (0700.HK) Income Statement Analysis – Financial Results
- Gladstone Investment Corporation (GAINL) Income Statement Analysis – Financial Results
- COSCO SHIPPING Development Co., Ltd. (601866.SS) Income Statement Analysis – Financial Results
- Close Brothers Group plc (CBG.L) Income Statement Analysis – Financial Results
- Sopharma AD (SPH.WA) Income Statement Analysis – Financial Results
Perfect Medical Industry Co., Ltd. (6543.TWO)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.perfectmedical.com.tw
About Perfect Medical Industry Co., Ltd.
Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally. It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes. The company also offers its products under the PF brand in Asia, Africa, Europe, and South America. Perfect Medical Industry Co., Ltd. was founded in 1989 and is headquartered in Changhua, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 734.13M | 677.04M | 724.61M | 807.76M | 675.71M |
| Cost of Revenue | 533.58M | 542.63M | 515.08M | 555.03M | 523.06M |
| Gross Profit | 200.56M | 134.41M | 209.53M | 252.73M | 152.65M |
| Gross Profit Ratio | 27.32% | 19.85% | 28.92% | 31.29% | 22.59% |
| Research & Development | 7.40M | 7.12M | 5.58M | 7.57M | 5.15M |
| General & Administrative | 80.57M | 60.25M | 75.35M | 67.22M | 54.70M |
| Selling & Marketing | 54.22M | 63.37M | 70.09M | 47.46M | 42.39M |
| SG&A | 134.78M | 123.61M | 145.44M | 114.68M | 97.09M |
| Other Expenses | 0.00 | 18.43M | 6.07M | 3.75M | 0.00 |
| Operating Expenses | 142.20M | 130.73M | 151.03M | 122.25M | 101.96M |
| Cost & Expenses | 675.77M | 673.37M | 666.11M | 677.28M | 625.03M |
| Interest Income | 2.47M | 355.00K | 1.17M | 2.05M | 132.00K |
| Interest Expense | 4.37M | 4.46M | 2.96M | 2.05M | 1.13M |
| Depreciation & Amortization | 56.86M | 55.78M | 48.40M | 39.48M | 31.70M |
| EBITDA | 115.48M | 78.24M | 114.14M | 175.75M | 82.10M |
| EBITDA Ratio | 15.73% | 11.56% | 15.75% | 21.76% | 12.15% |
| Operating Income | 58.37M | 22.45M | 65.74M | 136.27M | 50.41M |
| Operating Income Ratio | 7.95% | 3.32% | 9.07% | 16.87% | 7.46% |
| Total Other Income/Expenses | -4.12M | -4.48M | -3.22M | -2.82M | -537.00K |
| Income Before Tax | 54.25M | 17.98M | 62.52M | 133.44M | 49.87M |
| Income Before Tax Ratio | 7.39% | 2.66% | 8.63% | 16.52% | 7.38% |
| Income Tax Expense | 14.16M | 3.71M | 23.75M | 32.75M | 13.42M |
| Net Income | 40.09M | 14.27M | 38.77M | 100.69M | 36.44M |
| Net Income Ratio | 5.46% | 2.11% | 5.35% | 12.47% | 5.39% |
| EPS | 0.86 | 0.31 | 0.93 | 2.42 | 0.89 |
| EPS Diluted | 0.85 | 0.31 | 0.93 | 2.33 | 0.88 |
| Weighted Avg Shares Out | 46.55M | 44.97M | 41.34M | 41.69M | 41.06M |
| Weighted Avg Shares Out (Dil) | 46.90M | 45.03M | 41.34M | 43.03M | 41.22M |
Source: https://incomestatements.info
Category: Stock Reports